« Back to Record
Olender, S. A., Walunas, T. T., Martinez, E., Perez, K. K., Castagna, A., Wang, S., Kurbegov, D., Goyal, P., Ripamonti, D., Balani, B., De Rosa, F. G., De Wit, S., Kim, S. W., Diaz, G., Bruno, R., Mullane, K. K., Lye, D. C., Gottlieb, R. R., Haubrich, R., Chokkalingam, A. A., Wu, G., Diaz-Cuervo, H., Brainard, D. D., Lee, H. I., Hu, H., Lin, L., Osinusi, A. A., Bernardino, J. I., & Boffito, M. (2021). Remdesivir Versus Standard-of-Care for Severe Coronavirus Disease 2019 Infection: An Analysis of 28-Day Mortality. Open Forum Infectious Diseases, 8(7), ofab278. doi:10.1093/ofid/ofab278
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/331523



